Owners, management and financials
CVR: 17981994
Secondary names: Norpharma A/S
Previous names: A/S PSE 10 NR. 2061, NORPHARMA A/S, Norpharma A/S
DKK 25,912,000
Revenue
Net result: DKK 672,000
Halm S.à.r.l. (50-66,65%), RSS Captain Trust Holdings LLC (25-33,32%)
1 more
CVR · view owners
Lisbeth Kattenhøj
Board: Stephen Johan Jamieson (chair) and 2 members
CVR · view management
Active
Founded 1 August 1994
CVR · view overview
3 employees
CVR · 2026
Director registered: Lisbeth Kattenhøj
CVR · 26/07/2024
View the full event history
Mundipharma A/S is a Danish company of the type Aktieselskab based in Vedbæk, founded in 1994. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Norpharma A/S and NORPHARMA A/S. The management consists of Lisbeth Kattenhøj. The board consists of Stephen Johan Jamieson (chair), Bryan George Lea and Lisbeth Kattenhøj. The company is owned by Halm S.à.r.l., RSS Captain Trust Holdings LLC and JDS Captain Trust Holdings LLC. The company has 3 employees (2026). In 2025, the company reported revenue of DKK 25,912,000 and a net result of DKK 672,000 compared with DKK 514,000 the year before. Equity in the 2025 report amounted to DKK 38,165,000.
Source: annual report 2025, Danish Business Authority
Mundipharma A/S is experiencing a declining trend in revenue and profitability, with revenues decreasing from 48.5 million DKK in 2021 to 25.9 million DKK in 2025. Profit margins have also contracted, with profits falling from 909,000 DKK in 2021 to 672,000 DKK in 2025. The company's equity position remains relatively stable, increasing slightly from 36.98 million DKK in 2023 to 38.17 million DKK in 2025, indicating some resilience. However, the overall trajectory suggests challenges in maintaining market position within the pharmaceutical distribution industry.
AI-generated summary · Generated 27/06/2026
Selskabets formål er at drive handel og industri.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 25.9 mio. | 672 t. | 51.4 mio. | 38.2 mio. | 3 | |
| 202401/01/2024 – 31/12/2024 | 26.4 mio. | 514 t. | 53.9 mio. | 37.5 mio. | 2 | |
| 202301/01/2023 – 31/12/2023 | 35.9 mio. | 897 t. | 48.8 mio. | 37 mio. | 2 | |
| 202201/01/2022 – 31/12/2022 | 40.1 mio. | 709 t. | 61.1 mio. | 49.8 mio. | 4 | |
| 202101/01/2021 – 31/12/2021 | 48.5 mio. | 910 t. | 85.7 mio. | 49.1 mio. | 9 | |
| 202001/01/2020 – 31/12/2020 | 51.6 mio. | 908 t. | 128.6 mio. | 48.2 mio. | 21 | |
| 201901/01/2019 – 31/12/2019 | 53.5 mio. | 23 t. | 143.6 mio. | 47.3 mio. | 25 | |
| 201801/01/2018 – 31/12/2018 | 55.4 mio. | -152 t. | 136.7 mio. | 47.3 mio. | 26 | |
| 201701/01/2017 – 31/12/2017 | 63.3 mio. | -8.3 mio. | 138.4 mio. | 47.4 mio. | 23 | |
| 201601/01/2016 – 31/12/2016 | 73 mio. | 2.4 mio. | 147.2 mio. | 55.7 mio. | 41 | |
| 201501/01/2015 – 31/12/2015 | 2.8 mia. | 51.5 mio. | 436.7 mio. | 128.3 mio. | 39 | |
| 201401/01/2014 – 31/12/2014 | 2.4 mia. | 33.8 mio. | 1.1 mia. | 76.8 mio. | 44 | |
| 201301/01/2013 – 31/12/2013 | 2.1 mia. | 4.5 mio. | 998.4 mio. | 73 mio. | 48 |
Compared to 404 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
3 public tenders won
Sources: TED (the EU tender database) and udbud.dk
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningThe CVR number of Mundipharma A/S is 17981994.
Mundipharma A/S is owned by Halm S.à.r.l., RSS Captain Trust Holdings LLC and JDS Captain Trust Holdings LLC.
The management of Mundipharma A/S consists of Lisbeth Kattenhøj.
The board of Mundipharma A/S consists of Stephen Johan Jamieson, Bryan George Lea and Lisbeth Kattenhøj, with Stephen Johan Jamieson as chair.
In 2025, Mundipharma A/S reported revenue of DKK 25,912,000.
Mundipharma A/S had 3 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Mundipharma A/S has published its annual report for 2025. Revenue came to DKK 25,912,000, and the net result was DKK 672,000.
Contact info changed: new phone: 47174800 (June 24, 2026).
Contact info changed: new phone: 47174800 (June 22, 2026).
As of June 19, 2026, Bryan George Lea has joined the board of directors of Mundipharma A/S.
As of June 19, 2026, Elliot James Haddock has left the board of directors of Mundipharma A/S.
As of November 28, 2025, Elliot James Haddock has joined the board of directors of Mundipharma A/S.
As of November 28, 2025, Sarah Anna Heidrich has left the board of directors of Mundipharma A/S.
Mundipharma A/S has won the tender "Amgros 2026 1.607.a" issued by Amgros I/S worth 60,481,552 DKK.
Mundipharma A/S has won the tender "Amgros 2026 1.1203.a" issued by Amgros I/S worth 368,505,024 DKK.
Mundipharma A/S has won the tender "Amgros 2026 2.690.b" issued by Amgros I/S worth 217,081,515 DKK.
Mundipharma A/S has published its annual report for 2024. Revenue came to DKK 26,430,000, and the net result was DKK 514,000.
As of March 7, 2025, Stephen Johan Jamieson has joined the board of directors of Mundipharma A/S.
As of March 7, 2025, Sarah Anna Heidrich has joined the board of directors of Mundipharma A/S.
As of March 7, 2025, Jörg Fischer has left the board of directors of Mundipharma A/S.
As of March 6, 2025, Stephen Johan Jamieson has left the board of directors of Mundipharma A/S.
As of July 26, 2024, Lisbeth Kattenhøj has joined the board of directors of Mundipharma A/S.
As of July 26, 2024, Hywel Rhys Day has left the board of directors of Mundipharma A/S.
As of July 26, 2024, Floris Anne Everard Bongenaar has left the board of directors of Mundipharma A/S.
As of July 26, 2024, Lisbeth Kattenhøj is registered as director of Mundipharma A/S.
As of July 26, 2024, Hywel Rhys Day has stepped down as adm. dir. of Mundipharma A/S.
Mundipharma A/S has published its annual report for 2023. Revenue came to DKK 35,938,000, and the net result was DKK 897,000.
Mundipharma A/S has published its annual report for 2022. Revenue came to DKK 40,102,000, and the net result was DKK 709,000.
As of June 30, 2023, Hywel Rhys Day has joined the board of directors of Mundipharma A/S.
As of June 30, 2023, Floris Anne Everard Bongenaar has joined the board of directors of Mundipharma A/S.
As of June 30, 2023, Jennie Maria Synnöve Tjernström has left the board of directors of Mundipharma A/S.
As of June 30, 2023, Hywel Rhys Day is registered as adm. dir. of Mundipharma A/S.
As of June 30, 2023, Jennie Maria Synnöve Tjernström has stepped down as adm. dir. of Mundipharma A/S.
Mundipharma A/S has published its annual report for 2021. Revenue came to DKK 48,452,861, and the net result was DKK 909,958.
As of May 9, 2022, is registered as an owner of Mundipharma A/S with an ownership share of 25%.
As of May 9, 2022, is registered as an owner of Mundipharma A/S with an ownership share of 25%.
As of January 31, 2022, Jennie Maria Synnöve Tjernström has joined the board of directors of Mundipharma A/S.
As of January 31, 2022, Salvador Lopez Orland has left the board of directors of Mundipharma A/S.
As of December 3, 2021, Jennie Maria Synnöve Tjernström is registered as adm. dir. of Mundipharma A/S.
As of December 3, 2021, Salvador Lopez Orland has stepped down as adm. dir. of Mundipharma A/S.
Mundipharma A/S has published its annual report for 2020. Revenue came to DKK 51,563,000, and the net result was DKK 908,000.
As of January 22, 2021, Salvador Lopez Orland has joined the board of directors of Mundipharma A/S.
As of January 22, 2021, Kjetil Kollstad has left the board of directors of Mundipharma A/S.
As of January 15, 2021, Salvador Lopez Orland is registered as adm. dir. of Mundipharma A/S.
As of January 15, 2021, Kjetil Kollstad has stepped down as adm. dir. of Mundipharma A/S.
Mundipharma A/S has published its annual report for 2019. Revenue came to DKK 53,480,000, and the net result was DKK 23,000.
As of December 31, 2019, Jörg Fischer has joined the board of directors of Mundipharma A/S.
As of December 31, 2019, Kjetil Kollstad has joined the board of directors of Mundipharma A/S.
As of December 31, 2019, Stuart David Baker has left the board of directors of Mundipharma A/S.
As of December 30, 2019, Jörg Fischer has left the board of directors of Mundipharma A/S.
Mundipharma A/S has published its annual report for 2018. Revenue came to DKK 55,436,000, and the net result was DKK -152,000.
As of February 22, 2019, Stephen Johan Jamieson has joined the board of directors of Mundipharma A/S.
As of February 22, 2019, Åke Gunnar Wikström has left the board of directors of Mundipharma A/S.
Mundipharma A/S has published its annual report for 2017. Revenue came to DKK 63,266,000, and the net result was DKK -8,267,000.
As of April 1, 2018, Stuart David Baker has joined the board of directors of Mundipharma A/S.
As of April 1, 2018, Åke Gunnar Wikström has joined the board of directors of Mundipharma A/S.
As of April 1, 2018, Christopher Benbow Mitchell has left the board of directors of Mundipharma A/S.
As of March 31, 2018, Stuart David Baker has left the board of directors of Mundipharma A/S.
As of February 1, 2018, Kjetil Kollstad is registered as adm. dir. of Mundipharma A/S.
As of February 1, 2018, Anders With Fogstrup has stepped down as director of Mundipharma A/S.
Mundipharma A/S has published its annual report for 2016. Revenue came to DKK 72,961,000, and the net result was DKK 2,386,000.
On May 15, 2017, the company changed its name from Norpharma A/S to Mundipharma A/S.
On November 29, 2016, the company changed its name from Mundipharma A/S to Norpharma A/S.
On November 9, 2016, the company changed its name from NORPHARMA A/S to Mundipharma A/S.
Mundipharma A/S has published its annual report for 2015. Revenue came to DKK 2,830,314,000, and the net result was DKK 51,521,000.
Mundipharma A/S has published its annual report for 2014. Revenue came to DKK 2,387,911,000, and the net result was DKK 33,802,000.
As of October 10, 2014, EY Godkendt Revisionspartnerselskab has been appointed auditor of Mundipharma A/S.
As of October 10, 2014, JUT NR. 2180 A/S has stepped down as auditor of Mundipharma A/S.
As of October 1, 2014, Anders With Fogstrup is registered as director of Mundipharma A/S.
As of October 1, 2014, Per Wester has stepped down as director of Mundipharma A/S.
Mundipharma A/S has published its annual report for 2013. Revenue came to DKK 2,097,309,000, and the net result was DKK 4,453,000.
As of June 25, 2013, JUT NR. 2180 A/S has been appointed auditor of Mundipharma A/S.
As of June 25, 2013, JUT NR. 2180 A/S has stepped down as auditor of Mundipharma A/S.
Mundipharma A/S has published its annual report for 2012.
As of August 25, 2011, Per Wester is registered as director of Mundipharma A/S.
As of August 25, 2011, Kaare Madsen has stepped down as director of Mundipharma A/S.
As of March 25, 2009, Christopher Benbow Mitchell has joined the board of directors of Mundipharma A/S.
As of May 18, 2006, Jens Ole Nielsen has left the board of directors of Mundipharma A/S.
As of June 25, 2001, JUT NR. 2180 A/S has been appointed auditor of Mundipharma A/S.
As of June 25, 2001, has stepped down as auditor of Mundipharma A/S.
As of February 5, 2001, is registered as an owner of Mundipharma A/S with an ownership share of 50%.
As of June 2, 1999, Stuart David Baker has joined the board of directors of Mundipharma A/S.
As of December 29, 1998, Peter Tærø Nielsen has left the board of directors of Mundipharma A/S.
As of March 10, 1997, Jesper Knudsen has left the board of directors of Mundipharma A/S.
On December 24, 1994, the company changed its name from A/S PSE 10 NR. 2061 to NORPHARMA A/S.
As of December 23, 1994, Erik Tronborg Andersen has stepped down as auditor of Mundipharma A/S.
As of December 23, 1994, Hans Christian Galst has left the board of directors of Mundipharma A/S.
As of December 23, 1994, Ulf Svejgaard Poulsen has left the board of directors of Mundipharma A/S.
As of December 23, 1994, Per Emil Hasselbalch Stakemann has left the board of directors of Mundipharma A/S.
As of December 23, 1994, Per Emil Hasselbalch Stakemann has stepped down as director of Mundipharma A/S.
As of August 1, 1994, Erik Tronborg Andersen has been appointed auditor of Mundipharma A/S.
As of August 1, 1994, has been appointed auditor of Mundipharma A/S.
As of August 1, 1994, Jesper Knudsen has joined the board of directors of Mundipharma A/S.
As of August 1, 1994, Hans Christian Galst has joined the board of directors of Mundipharma A/S.
As of August 1, 1994, Peter Tærø Nielsen has joined the board of directors of Mundipharma A/S.
As of August 1, 1994, Ulf Svejgaard Poulsen has joined the board of directors of Mundipharma A/S.
As of August 1, 1994, Jens Ole Nielsen has joined the board of directors of Mundipharma A/S.
As of August 1, 1994, Per Emil Hasselbalch Stakemann has joined the board of directors of Mundipharma A/S.
As of August 1, 1994, Jörg Fischer has joined the board of directors of Mundipharma A/S.
As of August 1, 1994, Per Emil Hasselbalch Stakemann is registered as director of Mundipharma A/S.
As of August 1, 1994, Kaare Madsen is registered as director of Mundipharma A/S.
Mundipharma A/S was founded on August 1, 1994.
Companies in the same industry and area
CVR 34362440
CVR 37642185
CVR 44558254
CVR 59238213
CVR 32122337
